December 18th 2023: Partial Recognition of ISO 10993-17 (2023) Biological Evaluation of Medical Devices-Part 17 by the FDA
ISO 10993-17 (2023) Biological Evaluation of Medical Devices-Part 17—Toxicological Risk Assessment of Medical Device Constituents, was recognized (partially) by FDA today for implementation prior to December 20, 2026. ISO 10993-17 describes the toxicological risk assessment process for the evaluation of constituents identified in and extractables evaluation or similar chemical characterization and defines the acceptance criteria. […]